These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 33982956)
1. Off-Label Use of Multitarget Stool DNA Testing in Primary Care. Agarwal A; Zhang T; Ravindran N; Thuluvath PJ; Maheshwari A Am J Gastroenterol; 2021 Apr; 116(4):829-832. PubMed ID: 33982956 [TBL] [Abstract][Full Text] [Related]
2. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. Prince M; Lester L; Chiniwala R; Berger B World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082 [TBL] [Abstract][Full Text] [Related]
3. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy. Eckmann JD; Ebner DW; Bering J; Kahn A; Rodriguez E; Devens ME; Lowrie KL; Doering K; Then S; Burger KN; Mahoney DW; Prichard DO; Wallace MB; Gurudu SR; Finney LJ; Limburg P; Berger B; Ahlquist DA; Kisiel JB Am J Gastroenterol; 2020 Apr; 115(4):608-615. PubMed ID: 32068535 [TBL] [Abstract][Full Text] [Related]
4. Inappropriate Multi-Target Stool DNA Use for Colorectal Cancer Screening: Risks, Compliance, and Outcomes. Lazar NJ; Khreisat A; AlKloub R; Al-Hillan A; Duffy M Cureus; 2023 Jun; 15(6):e40506. PubMed ID: 37397671 [TBL] [Abstract][Full Text] [Related]
5. The Utility of Multitarget Stool DNA Testing for Colorectal Cancer Screening After a Normal Colonoscopy. Rao AK; Kalra S; Van Leer-Greenberg B; Rockey DC J Gastrointest Cancer; 2024 Oct; 56(1):2. PubMed ID: 39414672 [TBL] [Abstract][Full Text] [Related]
6. Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. Johnson DH; Kisiel JB; Burger KN; Mahoney DW; Devens ME; Ahlquist DA; Sweetser S Gastrointest Endosc; 2017 Mar; 85(3):657-665.e1. PubMed ID: 27884518 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Ladabaum U; Mannalithara A Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556 [TBL] [Abstract][Full Text] [Related]
8. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening. Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening. Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Sharma T Public Health; 2020 May; 182():70-76. PubMed ID: 32179290 [TBL] [Abstract][Full Text] [Related]
12. A novel multitarget stool DNA test for colorectal cancer screening. Malik P Postgrad Med; 2016; 128(2):268-72. PubMed ID: 26753807 [TBL] [Abstract][Full Text] [Related]
13. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening. Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933 [No Abstract] [Full Text] [Related]
14. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness. Berger BM; Schroy PC; Dinh TA Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032 [TBL] [Abstract][Full Text] [Related]
15. Performance of multitarget stool DNA testing in African American patients. Cooper GS; Markowitz SD; Chen Z; Tuck M; Willis JE; Berger BM; Brenner DE; Li L Cancer; 2018 Oct; 124(19):3876-3880. PubMed ID: 30193399 [TBL] [Abstract][Full Text] [Related]
16. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing. Voss JK; Ebner DW; Burger KN; Mahoney DW; Devens ME; Lowrie KL; Kisiel JB Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2399-2406. PubMed ID: 36621751 [TBL] [Abstract][Full Text] [Related]
17. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population. Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091 [TBL] [Abstract][Full Text] [Related]
18. Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing. Cooper GS; Grimes A; Werner J; Cao S; Fu P; Stange KC J Am Board Fam Med; 2021; 34(1):61-69. PubMed ID: 33452083 [TBL] [Abstract][Full Text] [Related]
19. Inappropriate Ordering of Multitarget Stool DNA Tests for Colon Cancer Screening. Ahn AB; Kulhari S; Rhee J; Cooper G J Am Board Fam Med; 2024; 37(2):328-331. PubMed ID: 38740492 [TBL] [Abstract][Full Text] [Related]
20. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry. Anderson JC; Robinson CM; Hisey WM; Edwards DK; Kneedler BL; Berger BM; Butterly LF J Clin Gastroenterol; 2022 May-Jun 01; 56(5):419-425. PubMed ID: 33973962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]